Effect of lyophilization on the in vitro biological activity of bevacizumab.
Taniwaki
L
L
Mendonça
R
R
Cunha-Júnior
A S
AS
Faraco
A A G
AA
Ribeiro
J A S
JA
Scott
I U
IU
Jorge
R
R
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D004355:Drug Stability; D005612:Freeze Drying; D011309:Preservation, Biological / Q000379:methods*; D042461:Vascular Endothelial Growth Factor A / Q000276:immunology*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab